ClinicalTrials.Veeva

Menu

Spot-Check Noninvasive Pulse CO-Oximeter Validation

Masimo logo

Masimo

Status

Completed

Conditions

Anemia

Treatments

Device: Masimo Rad-67 Pulse Oximeter

Study type

Interventional

Funder types

Industry

Identifiers

NCT02782806
TORR0001

Details and patient eligibility

About

In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.

Enrollment

368 patients

Sex

All

Ages

1+ month old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female
  • Age: Greater than one month
  • Weight: Greater than or equal to 3kg
  • Any racial or ethnic group
  • The subject or the subject's legally authorized representative has given written informed consent/assent to participate in the study
  • If an ICU patient, total hemoglobin of < 9 g/dL at time of screening.

Exclusion criteria

  • Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, nail polish, acrylic nails, infections, abnormalities, etc.
  • Subjects deemed not suitable for the study at the discretion of the investigator
  • Subjects unlikely to be able to refrain from excessive motion during data collection. Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

368 participants in 1 patient group

Test group
Experimental group
Description:
All subjects are enrolled into the test group and receive Masimo Rad-67 Pulse Oximeter for measurement of hemoglobin.
Treatment:
Device: Masimo Rad-67 Pulse Oximeter

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems